Why Is Stelara So Expensive
Why Is Stelara So Expensive – A Phase 3 study conducted by Amgen found that the company’s ustekinumab biosimilar was as safe and effective as the reference product (Stelara) in patients with moderate to severe plaque psoriasis. Amgen shared preliminary results from its Phase 3 study showing that the company’s ustekinumab biosimilar (ABP 654) has comparable safety and… Read More »